{"id":"NCT01720069","sponsor":"Vectura Limited","briefTitle":"Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma","officialTitle":"A Randomised Double-blind, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of VR506 From a New Dry Powder Inhaler in Subjects With Severe Persistent Asthma Requiring Oral Corticosteroid Therapy.","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2012-10","primaryCompletion":"2013-10","completion":"2013-10","firstPosted":"2012-11-01","resultsPosted":"2020-04-21","lastUpdate":"2020-04-21"},"enrollment":197,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"VR506","otherNames":[]}],"arms":[{"label":"Dose 1 VR506","type":"ACTIVE_COMPARATOR"},{"label":"Dose 2 VR506","type":"ACTIVE_COMPARATOR"},{"label":"Dose 3 VR506","type":"ACTIVE_COMPARATOR"}],"summary":"To evaluate the clinical efficacy, safety, tolerability and dose-response relationship, using oral corticosteroid (OCS) modulation, of 3 different doses of VR506 using a twice daily regimen from a new dry powder inhaler (nDPI) for 16 weeks in subjects with severe persistent asthma requiring OCS therapy, i.e. Step 5 treatment as defined by modified Global Initiative for Asthma (GINA) guidelines 2011.","primaryOutcome":{"measure":"Mean Prednisone/Prednisolone Dose for Analysis (PDA) at End of Study (Week 16)","timeFrame":"16 weeks","effectByArm":[{"arm":"Dose 1 VR506 50 mcg","deltaMin":4.55,"sd":6.85},{"arm":"Dose 2 VR506 250 mcg","deltaMin":4.31,"sd":7.38},{"arm":"Dose 3 VR506 500 mcg","deltaMin":3.97,"sd":6.21}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.772"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":77,"countries":["United States","Bulgaria","Germany","Hungary","Poland","Romania","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":62},"commonTop":["Asthma","Headache","Oropharyngeal pain","Respiratory tract infection","Acute sinusitis"]}}